References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Ciardielloetal(2000)AntitumoreffectandpotentiationofcytotoxicdrugsactivityinhumancancercellsbyZD-1839(Iressa),anepidermalgrowthfactorreceptor-selectivetyrosinekinaseinhibitor.Clin.CancerRes.62053PMID:10815932
Baselgaetal(2000)ZD1839('Iressa'),asananticanceragent.Drugs6033PMID:11129170
McKillopetal(2005)Tumorpenetrationofgefitinib(Iressa),anepidermalgrowthfactorreceptortyrosinekinaseinhibitor.Mol.CancerTher.4641PMID:15827338
Keywords:Iressa,supplier,Orally,active,selective,EGFR,inhibitors,inhibits,Epidermal,Growth,Factors,Receptors,ErbB,Her,Receptor,Tyrosine,Kinases,RTKs,AstraZeneca,ZD1839,chemotherapeutics,Gefitinib,ZD,1839,EGFR,EGFR,TocrisBioscience